Global Health Limited

High valuation (PE 68.78) leaves minimal room for earnings disappointment or multiple compression—verify revenue growth trajectory and what justifies the premium to peers.

Margin volatility: OPM ranges 18.55%–21.99% across recent quarters; understand the drivers (patient mix, capacity utilization, service pricing) and whether swings reflect operational risk or statistical noise.

Institutional selling pressure: FII stake declined from 10.15% to 9.46% in three months—verify whether this reflects fundamental concerns or sector rotation.

Bed occupancy, case complexity and patient retention metrics are not disclosed; verify these operational anchors to assess volume sustainability and pricing power.

Low financial leverage (D/E 0.3) provides capacity for bed expansion or acquisitions without balance-sheet stress; verify capex plans and new facility timelines.

Stable profitability (net profit ₹79.9–₹158.4 Cr per quarter) generates recurring cash for reinvestment; verify capital allocation policy and reinvestment rate.

Margin stability around 20% (OPM 20.84% average, range 18.55%–21.99%) means volume growth directly accrets to profit; verify current bed occupancy rates and case volume trends.